Researchers believe that in addition to producing antibodies against the virus, vaccines must also give rise to a cellular immune response.

The specific mode of transmission remains unknown.

Non-alcoholic fatty liver disease can be driven by toxin exposure.

Such risk factors include injecting drugs, being a man who has sex with men and being born in a region with a high prevalence of the virus.

Researchers have challenged findings from a Chinese study that concluded Baraclude is tied to a lower risk of liver cancer.

Researchers are seeking to understand why only 5% of babies born to mothers with hep C become infected.

Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.

For example, African Americans are more likely to have the virus compared with other races.

Researchers used an insurance database to estimate the hep B diagnosis rate.

A recent Swedish study defined a low-level detectable viral load as between 50 and 999.